Израильде ұйқы безінің қатерлі ісігіндегі операцияға бойынша ең жақсы дәрігерлер – ТОП-10 дәрігерлер

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Проф. Меримски Сураски медициналық орталығында Ортопедиялық онкология бөлімін басқарады, күрделі ұйқы безі қатерлі ісігі жағдайларына маманданған.

• Онкология саласында 25 жылдан астам тәжірибесі бар
• Гюстав Русси институтында жұмсақ тіндер мен сүйек саркомасы бойынша тағылымдамадан (феллоушип) өткен
• ESMO саркома факультетінің мүшесі
• Ісік иммунологиясы бойынша жарияланған зерттеулер

Сорски медициналық орталығында (Ихилов) ұйқы безі қатерлі ісігін, оның ішінде күрделі Уиппл процедурасын хирургиялық жолмен емдеуге маманданған.

• Гипертермиялық интраперитонеальды химиотерапияда (HIPEC) тәжірибелі
• Мақсатты терапия және иммунотерапия нұсқаларын ұсынады
• Қатерлі ісік ауруларын емдеу бойынша клиникалық зерттеулерге белсенді қатысады
• Ұйқы безі операцияларымен қатар бауыр резекцияларын орындайды

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Тель-Авив медициналық орталығының онкологиялық стационар директоры – доктор Степфанский күрделі қатерлі ісік жағдайларына арналған арнайы топты басқарады.

• Онкология саласында 15 жылдан астам тәжірибесі бар
• Ішкі аурулар және онкология бойынша маманданған
• Көптеген клиникалық онкологиялық зерттеулердің негізгі зерттеушісі
• Тель-Авив медициналық орталығында тағылымдамадан (fellowship) өткен

Доктор Клаузнер – один из лучших хирургов в Израиле, специализирующихся на операции Уиппла, а также Заведующий отделением хирургии в Медицинском центре Сураски.

• Специализируется на колоректальной, панкреатической и желудочно-кишечной хирургии
• Более 45 лет хирургического стажа
• Хирург, выполняющий большой объем операций, с обширным опытом в сложных случаях

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.